Investigation by development of technology of tincture for therapy of cardiovascular disease
Journal Title: Фармацевтичний журнал - Year 2014, Vol 1, Issue 1
Abstract
Development of new original multicomponent herbal medicinal products for prevention and treatment of cardiovascular disease and atherosclerosis, with the use of medicinal plants growing on the territory of Ukraine, are of current importance of pharmaceutical science. The aim of this work was the development of technology of herbal medicinal product for treatment of cardiovascular disease and atherosclerosis. Theoretically, taking into account the influence of each component into the final therapeutic effect of drug, such herbal composition «Atherophyt-norma» were chosen: Hawthorn fruit, Red Clover inflorescence, Hawthorn leaves with flowers, Low Cudweed grass in the ratio of 30:30:20:20. As the optimal dosage form for the drug «Atherophyt-norma» the tincture was selected. The laboratory samples of tincture were obtained by the method of subdivided maceration with the forced mixing. They were used for selection a solvent and study of the extraction process of bioactive substances. The extraction was carried out at the room temperature in the ratio of herbal drug to finished product 1:10. As the extraction solvent the ethanol with content of 40%, 50% and 70% was used. For quantitative evaluation of the efficiency of the extraction process and standardization of the drug the sum of flavonoids, the sum of procyanidins and dry residue were chosen. The kinetic regularities of the extraction process of herbal composition «Atherophyt-norma» were studied. It was established, that the best solvent for extraction of dry residue and bioactive substances by the method of subdivided maceration with dividing of solvent in 2 parts, with the ratio of herbal drug to finished product 1:10, was ethanol 50%.
Authors and Affiliations
K. O. Khokhlova
Keywords
Related Articles
- EP ID EP587434
- DOI -
- Views 80
- Downloads 0
Marketing analysis of the pharmaceutical market in Ukraine opioid analgesics
Opioid analgesics (OA) are essential medicines, in particularly for pain relief in palliative care. At the same time the problem of availability of this medicines for medical need is common in many countries. Among the c...
Modelling toxicity biologically active derivatives amides of pyridine carboxylic acids
At the present time attention is directed search for effective and non- toxic biologically active compounds. For search effective substances with the set properties requires thorough analysis and theoretical studies of p...
Development of emulgel technology with saw palmetto extracts and of japanese sophora tincture for androgenetic alopecia treatment
Androgenic alopecia is a hair disease caused by an excessive influence of androgens on hair follicles, whose treatment requires long-term use of systemic and / or local action drugs. In Ukrainian pharmaceutical market fo...
An influence of the cream with cerium dioxide nanoparticles on some vital signs of rats in the setting of a topical application in a chronic experiment
Melanoma and non-melanoma cancers are global healthcare problems nowadays. Ultraviolet (UV) radiation exposure is one of the risk factors of development of these pathologies. An introduction of sunscreen creams with ceri...
Marketing research ukrainian market antiplatelet agents
Antiplatelets are present at prevention and therapy of cardiovascular diseases necessarily. The aim of this work is organizing of informational file about medicines with antiplatelet activity, determination of actuality...